Position in BIIB
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,681,594
+$290,120 QoQ
Shares Held
7,783
+2.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#365
of 1,036 holders
Holding Since
Jun 2021
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Krilogy Financial LLC holds $34,255,416 across 11 Drug Manufacturers - General names. BIIB ranks #8 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,846 | $8,211,298 | |
| 2 | MRK |
Merck & Co., Inc.
|
40,378 | $5,188,573 | |
| 3 | JNJ |
Johnson & Johnson
|
18,676 | $4,743,143 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
72,415 | $4,172,552 | |
| 5 | ABBV |
AbbVie Inc.
|
15,832 | $3,983,964 | |
| 6 | PFE |
Pfizer Inc
|
88,365 | $2,127,829 | |
| 7 | AMGN |
Amgen Inc
|
5,876 | $2,127,817 | |
| 8 | BIIB |
Biogen Inc.
This page
|
7,783 | $1,681,594 |
All Filings in BIIB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,681,594 | 7,783 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,391,474 | 7,590 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,356,178 | 7,706 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,079,596 | 7,707 | Shares | Sole | 2025-11-06 | |
| 2021-06-30 | $226,806 | 655 | Shares | Sole | 2021-07-20 | |
| No filing history on record for this holder in this stock. | ||||||